November 2019 Issue Table Of Contents

From The Editor

• What’s The Next Big Thing Besides China?

Feature Articles

• How — And Why — John Oyler Built BeiGene
• From Medtech CEO To Impact Investor — Not Your Typical Retirement Plan

Capitol Perspectives

• Pelosi Bill's Head Shot To The Rx Industry

From Principles and Policy to Execution

• The Future of Healthcare Or Alice in Wonderland?

Companies To Watch

• Obsidian Therapeutics

Industry Research

• How Does Biopharma Outsource Clinical Logistics?

Inside The Industry

• How To Avoid Data-Integrity Woes In Pharma
• Crossing Over From Supplier To Sponsor
• 7 Elements Of A Successful Biotech Funding Plan
• How Biopharma Leaders Can Ward Off A Perfect Storm: Part 1
• Collecting Competitive Intelligence At Conferences
• Taking It All The Way To Phase 3 Clinical Trials
• Program Strives For More Females On Pharma Boards

Leadership Lessons

• How Dual-Career Couples Make It Work

Ask The Board

• What Advice Do You Have For Preventing Fraud Schemes In Large Phase 3 Studies?
• What Advice Do You Have For Executives Considering Ex-Pat Opportunities In South American Countries?
• What Advice Do You Have For An Executive Weighing An Exit From A Company For Which They Are A Leader And A Board Member?